Testicular Cancer Awareness Month emphasises importance of early detection

Date posted: 28th April 2026

April is Testicular Cancer Awareness Month, highlighting the symptoms of the most common cancer affecting younger men.

It is also one of the most survivable of all cancers, primarily because it is often detected early.

The message is clear, for all men to regularly check their testicles and if anything feels unusual or sore, consult a doctor.

Dr Neil Smith, primary care director at Lancashire and South Cumbria Cancer Alliance, said: “Testicular cancer is the most common cancer in UK men aged 15-49, but if detected early, it is one of the most treatable.

“The most common symptoms are usually a lump or swelling in a testicle, or a dull ache, pain, or heaviness in the scrotum. It also typically only affects one testicle, although in some cases it may be both.

“A lump in the scrotum is usually nothing to worry about – small cysts as a result of a fluid build-up are extremely common – but you should always get anything concerning checked out. A new lump or any unexplained pain, discomfort or swelling, especially if coming from the testicle, should always be examined by a doctor.”

The most recent statistics show that 96.5 per cent of people diagnosed with testicular cancer in the UK survive for 10 or more years, however, it is crucial that it is detected in its early stages.

While most campaigns raise awareness among younger men, it is still possible for testicular cancer to develop later in life. Each year around a fifth of testicular cancer deaths in the UK are in people aged 75 and over.

Dr Smith added: “Like any cancer, early detection is key. I’d encourage all men to check themselves regularly and feel for any lumps in the scrotum or anything that may seem a little bit different to normal.

“Even if you’re much older than the 15-49 bracket, you can still be affected, so never stop checking.”

For more information about the symptoms and treatment of testicular cancer, visit www.nhs.uk/conditions/testicular-cancer

Accessibility tools

Return to header